Dr. Hoenle AG/ DE0005157101 /
| 2021-09-21 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 51.6000USD | - | 1,000 Turnover: - |
-Bid Size: - | -Ask Size: - | 128.37 mill.USD | - | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.80 EUR | -178.43% |
| EPS Diluted: | -0.80 EUR | - |
| Revenues per Share: | 19.00 EUR | 22.68% |
| Book Value per Share: | 18.32 EUR | -4.47% |
| Cash Flow per Share: | 0.18 EUR | -84.72% |
| Dividend per Share: | 0.22 EUR | -56.00% |
| Total | in mill. | |
| Revenues: | 115.20 EUR | 22.68% |
| Net Income: | -4.80 EUR | -184.21% |
| Operating Cash Flow: | 1.10 EUR | - |
| Cash and Cash Equivalents: | 12.10 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 1.04 | 2.13 |
| P/BV ratio: | 1.08 | 2.21 |
| P/CF Ratio: | 109.41 | 223.23 |
| PEG: | 0.14 | - |
| Earnings Yield: | -4.03% | -1.98% |
| Dividend Yield: | 1.11% | 0.54% |
| Market Capitalization | ||
| Market Capitalization: | 128.37 mill. USD | 278.11 mill. USD |
| Free Float Market Cap.: | 88.32 mill. USD | 191.34 mill. USD |
| Market Cap. / Employee: | 192,452.6186 USD | 416,958.9639 USD |
| Shares Outstanding: | 6.06 mill. | |
Profitability
| Gross Profit Margin: | 23.18% |
| EBIT Margin: | 0.26% |
| Net Profit Margin: | -4.17% |
| Return on Equity: | -4.32% |
| Return on Assets: | -2.37% |
Financial Strength
| Liquidity I / Cash Ratio: | 43.68% |
| Liquidity II / Quick Ratio: | 105.42% |
| Liquidity III / Current Ratio: | 294.58% |
| Debt / Equity Ratio: | 82.63% |
| Dynam. Debt / Equity Ratio: | 8,345.45% |
Efficiency
| Employees: | 667 |
| Personal Expenses / Employee: | 59,370.31 EUR |
| Revenues / Employee: | 172,713.64 EUR |
| Net Income / Employee: | -7,196.40 EUR |
| Total Assets / Employee: | 304,197.90 EUR |
| * Fiscal Year End: | 2021-09-30 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
